Correcting Coagulopathy for Image-Guided Procedures

Overview

Journal Semin Intervent Radiol

Specialty Radiology

Date 2022 Nov 21

PMID 36406020

Authors

Paula M Novelli

Joshua M Tublin

Philip D Orons

Affiliations

Soon will be listed here.

Abstract

Patients with acquired coagulopathy often require percutaneous image-guided invasive procedures for urgent control of hemorrhage or for elective procedures. Routine preprocedural evaluation of coagulopathy previously focused on absolute prothrombin time, partial thromboplastin time, international normalized ratio, and platelet count values. Now viscoelastic testing and greater understanding of patient- and drug-specific changes in coagulation profiles can yield better coagulation profile data. More specific reversal agents and profiles combine for less generalized and more titrated transfusion or correction algorithms. This article reviews procedural and patient-specific factors for defining both hemorrhagic risk and correction strategies.

References

Whiting D, DiNardo J . TEG and ROTEM: technology and clinical applications. Am J Hematol. 2013; 89(2):228-32. DOI: 10.1002/ajh.23599. View

Grzegorski T, Andrzejewska N, Kazmierski R . Reversal of antithrombotic treatment in intracranial hemorrhage--A review of current strategies and guidelines. Neurol Neurochir Pol. 2015; 49(4):278-89. DOI: 10.1016/j.pjnns.2015.06.003. View

Broos K, Feys H, De Meyer S, Vanhoorelbeke K, Deckmyn H . Platelets at work in primary hemostasis. Blood Rev. 2011; 25(4):155-67. DOI: 10.1016/j.blre.2011.03.002. View

Hayakawa M . Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype. J Intensive Care. 2017; 5:14. PMC: 5282695. DOI: 10.1186/s40560-016-0200-1. View

Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H . Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol. 2014; 20(10):2595-605. PMC: 3949268. DOI: 10.3748/wjg.v20.i10.2595. View

Chai-Adisaksopha C, Hillis C, Siegal D, Movilla R, Heddle N, Iorio A . Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost. 2016; 116(5):879-890. DOI: 10.1160/TH16-04-0266. View

Greinacher A, Selleng K . Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program. 2011; 2010:135-43. DOI: 10.1182/asheducation-2010.1.135. View

Rowe A, Mahbubani P, Bucklin M, Clark C, Hamilton L . Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage. Pharmacotherapy. 2016; 36(11):1132-1137. DOI: 10.1002/phar.1848. View

Sarode R, Milling Jr T, Refaai M, Mangione A, Schneider A, Durn B . Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013; 128(11):1234-43. PMC: 6701181. DOI: 10.1161/CIRCULATIONAHA.113.002283. View

10.

Kumar S, Lim E, Covic A, Verhamme P, Gale C, Camm A . Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 74(17):2204-2215. DOI: 10.1016/j.jacc.2019.08.1031. View

11.

James R, Palys V, Lomboy J, Lamm Jr J, Simon S . The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage. Neurosurg Focus. 2013; 34(5):E6. DOI: 10.3171/2013.2.FOCUS1328. View

12.

Godier A, Fontana P, Motte S, Steib A, Bonhomme F, Schlumberger S . Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with.... Arch Cardiovasc Dis. 2018; 111(3):210-223. DOI: 10.1016/j.acvd.2017.12.004. View

13.

Levy J, Tanaka K, Dietrich W . Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology. 2008; 109(5):918-26. DOI: 10.1097/ALN.0b013e3181895bd8. View

14.

Holinstat M . Normal platelet function. Cancer Metastasis Rev. 2017; 36(2):195-198. PMC: 5709181. DOI: 10.1007/s10555-017-9677-x. View

15.

White R, McKittrick T, Hutchinson R, Twitchell J . Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med. 1995; 122(1):40-2. DOI: 10.7326/0003-4819-122-1-199501010-00006. View

16.

Reis S, DeSimone N, Barnes L, Nordeck S, Grewal S, Cripps M . The Utility of Viscoelastic Testing in Patients Undergoing IR Procedures. J Vasc Interv Radiol. 2016; 28(1):78-87. DOI: 10.1016/j.jvir.2016.09.015. View

17.

Hellstern P . Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency. Thromb Res. 1999; 95(4 Suppl 1):S7-12. DOI: 10.1016/s0049-3848(99)00078-x. View

18.

Tagariello G, Radossi P, Salviato R, Zardo M, De Valentin L, Basso M . Clinical relevance of isolated prolongation of the activated partial thromboplastin time in a cohort of adults undergoing surgical procedures. Blood Transfus. 2016; 15(6):557-561. PMC: 5649965. DOI: 10.2450/2016.0047-16. View

19.

Hofer S, Schlimp C, Casu S, Grouzi E . Management of Coagulopathy in Bleeding Patients. J Clin Med. 2022; 11(1). PMC: 8745606. DOI: 10.3390/jcm11010001. View

20.

Stravitz R, Lisman T, Luketic V, Sterling R, Puri P, Fuchs M . Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2011; 56(1):129-36. PMC: 4944117. DOI: 10.1016/j.jhep.2011.04.020. View